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Abstract
Background: Tuberculosis remains a serious public health threat and economic burden in Russia with escalating
rates of drug resistance against a background of growing HIV-epidemic. Samara Oblast is one of the regions of the
Russian Federation where more than 1% of the population is affected by the HIV-epidemic; almost half of the
cases are concentrated in the largely-industrial city of Togliatti with a population of 800 000.
Methods: We conducted a retrospective analysis of errors leading to death of HIV-positive patients in general
health care hospitals in Togliatti, Russia, in 2008. All (n = 29) cases when tuberculosis was established at autopsy as
a cause of death were included.
Results: Median length of hospital stay was 20 days; in 11 cases the death occurred within the first 24 hours of
admission. All cases were known to be HIV-positive prior to admission, however HAART was not initiated for any
case, and no relevant tests to assess severity of immunosupression were performed despite their availability. No
appropriate diagnostic algorithms were applied to confirm tuberculosis. Major gaps were identified in the work of
hospital and consulting physicians including insufficient records keeping. In almost all patients earlier regular HIV-
relevant tests were not performed due to poor compliance of patients, many of whom abused alcohol and drugs.
Conclusions: We conclude that introduction of prompt and accurate diagnostics tests, adequate treatment
protocols and intensive training of physicians in management of AIDS and TB is vital. This should include reviewing
standards of care for HIV-positive individuals with accompanying social problems.
Background
Tuberculosis (TB) remains a serious public health threat
and economic burden in the Russian Federation with
escalating rates of multi- and extensive drug resistance
(MDR and XDR) against a background of poor infection
control and active spread of resistance strains [1,2]. At
the end of the 1990s, the HIV-epidemic emerged and is
now spreading fast across the country with the number
of registered cases being close to half a million by the
end of 2009 [3]; the number of HIV-TB co-infection
cases is increasing and according to national data TB is
one of the most common causes of death of HIV-
infected patients [4,5]. Due to the recent nature of the
epidemic and the poor availability of antiretroviral drugs
until recent years [6], Russian physicians have relatively
limited experience of the diagnosis and treatment of
HIV/AIDS cases and opportunistic infections [7-9]
Samara Oblast is one of the regions of the Russian
Federation where more than 1% of the population is
affected by the HIV-epidemic (over 42 000 registered
cases by end-2010; population 3.3 million) [10]. Almost
half of the cases are concentrated in the largely-indus-
trial city of Togliatti with a population of 800 000. TB
incidence and mortality rates among HIV-positive
patients there are several-fold higher than among the
general population (602.0/100 000 and 48.6/100 000 ver-
sus 83.4/100 00 and 9.5/100 000 respectively) [11].
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TB-related deaths among HIV-positive patients admitted
to general health care (GHC) hospitals in Togliatti, in
2008, with a diagnosis of TB established by post-mortem
autopsy analysis (undiagnosed while the patients were
alive). The study was initiated by Togliatti lead TB phy-
sicians with the objective of identifying diagnostic errors
that had led to misdiagnosis of TB.
Methods
Study Settings
All general health care (GHC) hospitals in Togliatti.
Study Population
All cases (n = 29) of death occurring in HIV-positive
patients, in 2008, admitted via the emergency room into
GHC hospitals in Togliatti with TB established as a
cause of death at autopsy.
Data Collection and Diagnostic Procedures
We collected medical data from each participant’sc a s e
histories and autopsy reports. As the study was performed
retrospectively, no additional interviews of relatives, physi-
cians or further laboratory examinations were conducted.
All presented information reflects the total data available
and includes data on age at time of death, date of hospital
admission, in-patient medical diagnosis at time of death,
stage of the HIV infection, current HIV treatment history,
history of TB in the past, and autopsy results.
Informed consent for autopsy was obtained from
patients’ relatives in all cases at the time of death. A
limited autopsy was performed on all cases according to
standard protocols for establishing the cause of death of
all patients deceased at hospital settings [12]. Represen-
tative samples of internal organs were fixed in 10% for-
malin solution, in order to preserve the tissue for
histological examination. Detailed description of all
changes found macroscopically and microscopically was
documented. Prior to microscopy, all tissue sections
were stained routinely with haematoxylin and eosin. For
each major organ, a maximum of three sections were
taken. To detect acid-fast bacilli a section from every
lobe of the lungs, one from the left and right main
bronchus and trachea, the hilar and mediastinal lymph
nodes was taken. Fresh gloves and blades were used for
every organ sampled. Tissue sections were treated with
special stains including Ziehl-Neelsen for acid-fast
bacilli, Gram’s stain for bacteria, periodic acid-Schiff for
fungi and Giemsa stain for Pneumocystis jeroveci.I n
100% of cases TB was established as the cause of death.
Statistical Analysis
A descriptive analysis was conducted identifying the
main characteristics of patients recruited into the
study and the causes of death as reflected in the case
histories.
Ethical Approval
The study was approved by the Samara Ministry of
Health and Social Development Ethics Review Board
and received a waiver of informed consent due to the
retrospective nature of the study and absence of addi-
tional procedures or additionally collected data.
Results
All patients included in the analysis were admitted to
GHC hospitals as emergency cases. They were known to
be HIV-positive before hospital admission and clinical
notes available at admission reflected that all were regis-
tered as patients at the city AIDS Center; all presented
with advanced stages of infection (B2-B3 according to
the CDC classification) [13].
The median length of hospital stay prior to death was
20 days (range 1 hour to 91 days); however in 11 cases
death occurred within the first 24 hours of admission.
The majority of cases were males (n = 20; 69%). The
median age was 32 years (range of 23-51 years). Most
patients belonged to a socially disadvantaged group and
8 6 %o ft h e m( n=2 5 )w e r eu n e m p l o y e d .T h ev a s t
majority (n = 26; 90%) had reported alcohol and drug
abuse. All patients who reported drug-abuse also had
accompanying hepatitis B and/or C infection.
Clinically, at admission the vast majority of patients
presented with fever, fatigue, cough, and alcohol or drug
intoxication (Table 1).
Although all patients were known to be HIV-positive,
in none of the cases during the three months prior to
hospital admission was a CD4 count or viral load (VL)
test performed (usually due to the patients missing their
a p p o i n t m e n t ;t h e s et e s t sa r ef r e eo fc h a r g ef o ra l l
patients). At admission, the CD4 count was performed
in 7 (24%) patients and VL level was measured in one
patient only. In cases when death occurred within the
Table 1 Clinical symptoms of patients at admission to
the hospitals (n = 29)
Symptom N %
Cough 23 79
Haemoptysis 2 7
Shortness of breath 8 29
Night sweats 26 90
Chest pain 5 17
Fatigue 29 100
Sudden weight loss 24 83
Fever 29 100
Alcohol intoxication symptoms 17 59
Drug intoxication symptoms 8 28
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Page 2 of 5first 24 hours of admission failure to run these tests was
explained by the very short time between admission and
death while in other cases no reasons were provided. In
all seven tested cases the CD4 count was significantly
below 200 cells/ml
3. None of the patients received
highly active antiretroviral therapy (HAART) prior to
admission.
In all cases a chest X-Ray (CXR) was performed, how-
ever, no abnormalities consistent with TB were reported
initially. In twelve cases other abnormalities of an uni-
dentified nature were reported. In these cases, a second
routine review of the CXR was performed by radiolo-
gists who were not blinded towards the results of the
first examination. It suggested that ten cases (35%) were
presumptively TB arguing that there might have been
an atypical presentation due to the advanced stage of
immunosuppression. In two of these patients, TB was
suspected by radiologists based on the presence of
enlarged intrathoracic lymph nodes. In seven cases
(24%) patients were referred for a CT scan and these
results prompted GHC physicians to suspect TB in four
of these cases.
Tuberculin testing was performed in 17 patients
whose length of hospital stay was longer than 5 days
(59% of all patients) but the result was negative in all
cases. Eleven patients (38%) were subjected to commer-
cially available serological tests to detect M. tuberculosis
antibodies: one case was “positive” and “negative” results
in the remaining ten cases were used as a further (incor-
rect) proof of rejection of TB as a possible diagnosis.
In all 29 cases a sputum sample was microscopically
examined for the presence of acid-fast bacilli by the
GHC laboratories according to national standards of
hospital care for newly admitted HIV-positive patients.
However, only in three patients (10%) was more than
one sputum sample taken despite current national and
international recommendations [14-16]. Microscopy
results were negative in all cases. No culture examina-
tion for TB or general microbiology was performed.
Overall despite the apparent negative results, in one
third of the cases (n = 9) GHC physicians believed that
TB was a differential diagnosis. HIV consultants and TB
physicians were invited to review 19 (66%) patients;
however they had rejected a possible diagnosis of tuber-
culosis and insisted on further investigation arguing that
the symptoms were explained by other accompanying
conditions.
All admitted patients received broad spectrum anti-
bacterial therapy that included co-trimoxazole, cephalos-
porins and erythromycin. None were given HAART or
anti-tuberculous therapy; unfortunately without per-
forming a CD4 the usual trigger for ARV therapy would
not have been met.
The autopsy results confirmed that in 16 cases (55%)
M. tuberculosis was both extrapulmonary as well as pul-
monary; in 5 patients (17%) in addition to pulmonary
TB, TB meningitis was diagnosed (Table 2).
In over half of the patients (n = 17; 59%) other oppor-
tunistic infections were diagnosed (Table 3).
Discussion
In middle- and high incidence TB countries this disease
is one of the commonest opportunistic infections affect-
ing HIV-positive people causing the majority of AIDS-
associated death. Altered immune response leads to aty-
pical clinical presentation of TB resulting into miss-
diagnosis and an extremely rapid progression to death
[17-19].
T h ei n i t i a t i o no ft h es t u d yw a st r i g g e r e db yl e a dT B
physicians in Togliatti who were concerned that active
TB was not recognized in deceased patients. In all study
cases, known risk factors for TB were reflected in the
medical charts but were not taken into account by treat-
ing physicians. Negative tuberculin tests, atypical radi-
ological presentation, and non-specific symptoms did
not exclude TB in HIV-positive patients but simply
reflected severe immunosupression and should have
prompted tuberculosis physicians to consider it as a
possible diagnosis.
Unfortunately essential tests for CD4 count were per-
formed in few patients only despite their wide availabil-
ity; ironically almost all patients were tested for the
presence of mycobacterial antibodies, i.e. largely worth-
less tests that are not recommended by national and
international guidelines due to their very low specificity.
A recently issued policy statement by the World Health
Organisation advises strongly against the use of com-
mercial serological assays presenting evidence for their
inconsistent and imprecise findings [20]. Unfortunately
the negative results of the serological tests were inter-
preted as proof against TB as a differential diagnosis.
However, the very short time between admission and
death in several cases might have limited the chances of
hospital physicians to perform the full range of
Table 2 Autopsy results (n = 29)
Lung and intrathoracic lymph nodes TB lesions (N, %) Additional TB lesions detected in (n, %): TB sepsis
(N, %)
Meninges Endocardium Liver and kidneys
26 (90%) 7 (24%) 1 (3%) 15 (52%) 3 (10%)
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Page 3 of 5diagnostic tests. The very severe clinical presentation of
these patients might have influenced treating physicians
to choose a palliative care approach and not to pursue
aggressive diagnostic and treatment strategies. Unfortu-
nately, due to the very limited routine clinical data avail-
able we can only hypothesise rather than make
conclusive statement.
Invited TB consultants and HIV physicians rejected
the possibility of TB despite radiological reports suggest-
ing TB as a possible diagnosis. Unfortunately only
microscopy was performed on patients’ sputum - test of
a low sensitivity especially in the setting of GHC institu-
tions not specializing in tuberculosis diagnosis; rapid
molecular screening tests and bacteriological culture
which would have been very helpful and are available in
t h ec i t yw e r en o tp e r f o r m e d .A sar e s u l t ,a l lp a t i e n t s
remained at GHC hospitals without being referred to
specialized TB units, and received neither anti-tubercu-
losis treatment nor HAART. Remaining in general
wards of the GHC hospitals, these patients were poten-
tial sources of infection for other patients. Although
drug susceptibility testing was not available for these
patients, extremely high rates of drug resistance includ-
ing MDR have been reported in this region [21,22] and
the deceased patients could have been infected with
resistant strains further exacerbating infection control
problems.
None of the patients received HAART prior to admis-
sion and physicians at the AIDS center stated that the
reason for this was the assumption of a high probability
of non-adherence among those patients; a limited avail-
a b i l i t yo fH A A R Tw o u l dp r e s u m a b l yh a v ei n f l u e n c e d
the decision not to initiate treatment. In addition many
of these patients (n = 20, 69%) failed to present at regu-
lar check-ups making it difficult for physicians to initiate
and maintain therapy. These findings do not necessarily
reflect inadequate care by AIDS physicians but rather
point to a strong need to improve social support and
adherence of marginalized HIV-infected individuals
including treatment of alcohol and drug-abuse.
Limitations
The study has several limitations. Due to its retrospec-
tive nature, gathered information could only reflect the
data available from medical charts and autopsy reports
which were often incomplete and did not necessarily
contain the desired level of detail. However, this analysis
is the first attempt by tuberculosis physicians at the
level of a large Russian city to openly identify several
major gaps in the work of TB, AIDS and general care
physicians. The use of autopsy-proven TB cases gave a
clear point of reference for an analysis of diagnostic
errors and patients’ death clearly suggested the potential
for diagnostic delay and poor management. The findings
are particularly relevant for Togliatti as one of the cities
most affected by the HIV-epidemic in Russia. Moreover,
for a city with considerable wealth and a developed
medical infrastructure, one might assume the availability
of a high level of medical expertise but the study sug-
gested the opposite.
Conclusions
Intensive training of physicians in diagnostics and man-
agement of AIDS and AIDS-associated illnesses and
improvement of their understanding of the benefits and
limitations of laboratory diagnosis is vital and has now
taken place as a result of this study. It is important to
increase awareness of TB amongst general physicians
and that TB can occur at any stage of HIV-infection as
well as its frequent atypical presentation in severely
immunosuppressed individuals. When TB is suspected,
two to three sputum samples should be examined both
microscopically and using a li q u i d( a n ds o l i d )c u l t u r e
method while anti-TB treat m e n ts h o u l db ei n i t i a t e d
promptly without awaiting for the bacteriological results.
Introduction of rapid molecular diagnostics for TB and
drug resistance is essential in these settings. Similarly
early and appropriate initiation of HAART therapy is
essential. Social support and treatment of accompanying
alcohol- and drug-abuse are necessary to ensure better
adherence of marginalized HIV-infected individuals to
diagnostic procedures and treatment.
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Table 3 Opportunistic infections diagnosed post-mortem
in HIV-patients died from TB (n = 29)
Illness Frequency
N%
Candidiasis 7 24
Herpes 6 21
PCP 1 3
Rotavirus infection 1 3
CMV 1 3
PCP - pneumocyctic pneumonia.
CMV - cytomegalovirus
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